Search

Your search keyword '"Language Development Disorders pathology"' showing total 151 results

Search Constraints

Start Over You searched for: Descriptor "Language Development Disorders pathology" Remove constraint Descriptor: "Language Development Disorders pathology"
151 results on '"Language Development Disorders pathology"'

Search Results

1. De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay.

2. Characterising the Long-Term Language Impairments of Children Following Cerebellar Tumour Surgery by Extracting Psycholinguistic Properties from Spontaneous Language.

3. Lesion-symptom mapping of language impairments in people with brain tumours: The influence of linguistic stimuli.

4. Structural brain abnormalities and their association with language impairment in school-aged children with Autism Spectrum Disorder.

5. CHL1 deletion is associated with cognitive and language disabilities - Case report and review of literature.

6. Co-Occurring Heterozygous CNOT3 and SMAD6 Truncating Variants: Unusual Presentation and Refinement of the IDDSADF Phenotype.

7. Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.

8. A case of Ververi-Brady syndrome due to QRICH1 loss of function and the literature review.

9. 14q32.11 microdeletion including CALM1, TTC7B, PSMC1, and RPS6KA5: A new potential cause of developmental and language delay in three unrelated patients.

10. Speech, Language, and Oromotor Skills in Patients With Polymicrogyria.

11. Pathogenic variants in TNRC6B cause a genetic disorder characterised by developmental delay/intellectual disability and a spectrum of neurobehavioural phenotypes including autism and ADHD.

12. A de novo BRPF1 variant in a case of Sudden Unexplained Death in Childhood.

13. Developmental delay, intellectual disability, short stature, subglottic stenosis, hearing impairment, onychodysplasia of the index fingers, and distinctive facial features: A newly reported autosomal recessive syndrome.

14. Novel de novo TRIP12 mutation reveals variable phenotypic presentation while emphasizing core features of TRIP12 variations.

15. A Private 16q24.2q24.3 Microduplication in a Boy with Intellectual Disability, Speech Delay and Mild Dysmorphic Features.

16. Chromosome 15q BP3 to BP5 deletion is a likely locus for speech delay and language impairment: Report on a four-member family and an unrelated boy.

17. Defining language disorders in children and adolescents with Noonan Syndrome.

18. Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.

19. Neuro-Clinical Signatures of Language Impairments: A Theoretical Framework for Function-to-structure Mapping in Clinics.

20. Neuro-Clinical Signatures of Language Impairments after Acute Stroke: A VBQ Analysis of Quantitative Native CT Scans.

21. Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).

22. The impact of expressive language development and the left inferior longitudinal fasciculus on listening and reading comprehension.

23. Grey matter volume in developmental speech and language disorder.

24. Clinical delineation of 18q11-q12 microdeletion: Intellectual disability, speech and behavioral disorders, and conotruncal heart defects.

25. De novo and biallelic DEAF1 variants cause a phenotypic spectrum.

26. Altered topological characteristics of morphological brain network relate to language impairment in high genetic risk subjects and schizophrenia patients.

27. White matter alterations and tract lateralization in children with dyslexia and isolated spelling deficits.

28. Altered gray matter volumes in language-associated regions in children with developmental language disorder and speech sound disorder.

29. Speech and language delay in a patient with WDR4 mutations.

30. Language outcome related to brain structures in school-aged preterm children: A systematic review.

31. Atypical Callosal Morphology in Children with Speech Sound Disorder.

32. Associations Between the 2D:4D Proxy Biomarker for Prenatal Hormone Exposures and Symptoms of Developmental Language Disorder.

33. Subcortical Brain and Behavior Phenotypes Differentiate Infants With Autism Versus Language Delay.

34. Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.

35. Clinical phenotype of ASD-associated DYRK1A haploinsufficiency.

36. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.

37. Structural brain abnormalities in a single gene disorder associated with epilepsy, language impairment and intellectual disability.

38. Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?

39. Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice.

40. Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability.

41. Dyslexia and language impairment associated genetic markers influence cortical thickness and white matter in typically developing children.

42. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.

43. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.

44. The Arcuate Fasciculus and Language Development in a Cohort of Pediatric Patients with Malformations of Cortical Development.

45. Neuroanatomy of Individual Differences in Language in Adult Males with Autism.

46. Relationship Between Surface-Based Brain Morphometric Measures and Intelligence in Autism Spectrum Disorders: Influence of History of Language Delay.

47. Compound heterozygote CDK5RAP2 mutations in a Guatemalan/Honduran child with autosomal recessive primary microcephaly, failure to thrive and speech delay.

48. A maternally inherited 16p13.11-p12.3 duplication concomitant with a de novo SOX5 deletion in a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features.

49. Phenotypic variation of TTC19-deficient mitochondrial complex III deficiency: a case report and literature review.

50. Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes.

Catalog

Books, media, physical & digital resources